- Home
- MYI vs IRMD Comparison
MYI vs IRMD Comparison
Compare MYI & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYI
- IRMD
- Stock Information
- Founded
- MYI 1992
- IRMD 1992
- Country
- MYI United States
- IRMD United States
- Employees
- MYI N/A
- IRMD N/A
- Industry
- MYI Investment Bankers/Brokers/Service
- IRMD Medical/Dental Instruments
- Sector
- MYI Finance
- IRMD Health Care
- Exchange
- MYI Nasdaq
- IRMD Nasdaq
- Market Cap
- MYI 723.2M
- IRMD 662.5M
- IPO Year
- MYI N/A
- IRMD 2014
- Fundamental
- Price
- MYI $10.92
- IRMD $52.41
- Analyst Decision
- MYI
- IRMD Strong Buy
- Analyst Count
- MYI 0
- IRMD 1
- Target Price
- MYI N/A
- IRMD $72.00
- AVG Volume (30 Days)
- MYI 256.7K
- IRMD 37.0K
- Earning Date
- MYI 01-01-0001
- IRMD 05-01-2025
- Dividend Yield
- MYI 4.81%
- IRMD 1.30%
- EPS Growth
- MYI N/A
- IRMD 11.11
- EPS
- MYI N/A
- IRMD 1.50
- Revenue
- MYI N/A
- IRMD $73,242,121.00
- Revenue This Year
- MYI N/A
- IRMD $10.58
- Revenue Next Year
- MYI N/A
- IRMD $17.74
- P/E Ratio
- MYI N/A
- IRMD $35.59
- Revenue Growth
- MYI N/A
- IRMD 11.71
- 52 Week Low
- MYI $9.32
- IRMD $40.18
- 52 Week High
- MYI $11.70
- IRMD $63.29
- Technical
- Relative Strength Index (RSI)
- MYI 43.30
- IRMD 42.14
- Support Level
- MYI $10.85
- IRMD $51.75
- Resistance Level
- MYI $11.25
- IRMD $53.18
- Average True Range (ATR)
- MYI 0.12
- IRMD 1.38
- MACD
- MYI -0.00
- IRMD 0.26
- Stochastic Oscillator
- MYI 36.54
- IRMD 54.71
About MYI Blackrock MuniYield Quality Fund III Inc
BLACKROCK MUNIYIELD QUALITY FUND III, INC. is a investment management company. Its investment objective is to provide shareholders with a high level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in various sectors such as Transportation; Utilities; Health; Education; Tobacco and others.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.